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Abstract: While all the organs of the human body works together for the proper functioning of the entire human system, the 
significant roles played by the heart, kidney and liver in the lives of humans cannot be overemphasized. The heart, kidney and 
liver shares one thing in common, namely: the blood from where several parameters that defines the state of human health can 
be deduced or inferred. This paper is on the comparative study of the possible symptoms of impending human heart, kidney 
and liver failures based on blood samples that could be used to infer the state of human health with a view for the development 
of an online real-time electronic health (e-health) monitoring system. The comparative study considered in this work identified 
19 vital measurable blood-related parameters that can be classified as follows: 1). Heart: heart beat, mean arterial blood 
pressure, systolic blood pressure, diastolic blood pressure; 2). Kidney: packed cell volume/blood cells, erythropoietin, 
electrolyte Na
+
, electrolyte Cl
-
, electrolyte Ca
2+
, vitamin D; and 3). Liver: Ceratine, glucose fasting, glucose random, urea, 
direct bilirubin, total bilirubim (direct and indirect), ammonia level, alpha-feto protein. Detailed discussion on the functions, 
tests and diagnosis of each of heart, kidney and liver as well as the causes, symptoms, failures, consequences (acute or chronic 
adverse effects) are also presented. Finally, some preliminary medical advice and suggestions on possible ways to circumvent, 
reduce and/or manage any impending symptoms of failures of the heart, kidney and/or liver based on the nominal values as 
well as the minimum and maximum values of the mentioned 19 parameters are given. 
Keywords: Blood Samples, Comparative Study, E-health, Heart, Kidney, Liver, Measurable Blood-Related Parameters, 
Organ Failures 
 
1. Introduction 
The importance of making a correct medical diagnosis 
cannot be over-stressed. There are emotional, legal and 
financial consequences if an individual is told that he/she is 
ill when, in fact, he/she is not. The patient suffers extreme 
emotional distress; the physician may be legally liable for 
this distress, and, in this time of managed health care, costs 
for unnecessary medical procedures are incurred. Of far 
greater consequence, is an improper diagnosis concluding the 
patient is disease-free when they are not. If proper treatment 
is withheld due to this misdiagnosis, the patient will suffer 
and possibly die unnecessarily. Any technology that can 
improve the ability to correctly diagnose human illness is a 
needed advance to humanity’s wellbeing. With the 
widespread use of electronic data capture and automation of 
medical records, medical diagnostic decision support systems 
(MDDSS) have become a valuable aid in improving the 
accuracy of medical diagnosis [1–5].  
The heart, kidney and/or liver failure is a life-threatening 
condition that demands early detection as well as urgent 
medical attention. The failure of all or any of these three 
organs can be acute (over days or weeks) or chronic (over 
months or years). The heart, kidney and liver share one thing 
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in common, namely: the blood from where human state of 
health can be deduced and/or inferred. For the heart, 
uncontrolled high blood pressure (hypertension) is a major 
cause of heart failure even in the absence of a heart attack [6–
9]. On the other hand, while kidney ensures the removal of 
waste and excess fluid from the blood, kidney failure raises 
the risk of other cardiovascular problems such as blockage of 
blood to the heart and congestive heart failure [10–16]. Apart 
from the liver’s main job of filtering the blood coming from 
the digestive track before passing it to the rest of the body; 
the liver also carry out a large number of critical functions 
including the manufacture of essential proteins and 
metabolism of fats and carbohydrates, eliminates harmful 
biochemical waste products, and secretes bile that contains 
bile acids which aid in the digestion and intestinal absorption 
of fats and vitamins [17–22]. 
Heart failure does not mean that the heart has stopped 
working. Rather, it means that the heart’s pumping power is 
weaker than normal. With heart failure, blood moves through 
the heart and body at slower rate and the pressure in the heart 
increases. As a result the heart cannot pump enough oxygen 
and nutrients to meet the body’s needs [23]. The chambers of 
the heart may respond by stretching to hold more blood to 
pump through the body or by becoming stiff and thickened. 
This helps to keep the body moving, but the heart muscle 
walls may eventually weaken and become unable to pump 
efficiently [24]. As a result, the kidney may respond by 
causing the body to retain fluid (water) and salt. If fluid 
builds up in the arms, legs, ankle, feet, lungs or other organs 
the body becomes congested, and congested heart failures is 
the term used to describe the condition [6–9, 25]. 
Kidney failure occurs when the kidney is no longer able to 
remove waste from the body. Kidney failure can happen 
suddenly or gradually [26]. People with kidney failure need 
dialysis or a transplant to stay alive. Acute kidney injury 
(also called acute renal failure) means that the kidney have 
suddenly stopped working, kidney remove waste products 
and help balance water and salt and other minerals 
(electrolyte) in the body [26]. When the kidney stops 
working, waste products, fluid and electrolyte builds up in 
the body which can cause problems that could be deadly. The 
kidneys are two organs located on either side of the spine in 
the middle at the back just above the waist. They perform 
several life sustaining roles [26]. They cleanse the blood by 
removing waste and excess fluids, maintain the balance of 
salt and mineral in the blood and help regulate blood pressure. 
When the kidney become damaged, waste products and fluid 
can build up in the body thereby causing swelling in the body 
ankles, vomiting, weakness, poor sleep and shortness of 
breath if left untreated. Diseased kidney may eventually stop 
functioning completely. Loss of kidney function is a serious 
and potentially fatal condition [10–16, 25] 
The liver is a vital organ of the digested system present in 
vertebrates and some other animals. It has a wide range of 
functions, including detoxification, protein synthesis, and 
production of biochemical necessary for digestion. The liver 
is necessary for survival. There is currently no way to 
compensate for the absence of liver function in the long 
term, although new liver dialysis techniques can be used in 
the short term [27]. This gland plays a major role in 
metabolism and has a number of functions in the body, 
including glycogen storage, decomposition of red blood 
cells, plasma protein synthesis, hormone production and 
detoxification. It lies below the diaphragm in the 
abdominal-pelvic region of the abdomen. It produces bile, 
an alkaline compound which aids in digestion via the 
emulsification of lipids [28]. The liver’s highly specialized 
tissues regulate a wide variety of high volume biochemical 
reactions, including the synthesis and breaking down of 
small and complex molecules, many of which are necessary 
for normal vital function [17–22, 29]. 
The liver is reddish brown organ with four lobes of 
unequal size and shape. The human liver normally weighs 
1.44 to 1.66 kg and is a soft, reddish-brown, triangular organ. 
It is both the large internal organ (the skin being the largest 
organ overall) and the largest gland in the human body. It is 
located in the right upper quadrant of the abdominal cavity, 
resting just below the diaphragm. The liver lies to the right of 
the stomach and overlies the gallbladder. It is connected to 
two large blood vessels, one called the hepatic artery and the 
other called portal vein. The hepatic artery carries blood from 
the aorta, whereas the portal vein carries blood containing 
digested nutrient from the entire gastrointestinal tract and 
also from the spleen and pancreas. These blood vessels 
subdivide into capillaries, which then leads to a lobule. Each 
lobule is made up of millions of hepatic cells which are in 
basic metabolic cells. The lobules are the functional units of 
the liver [30]. 
In this paper, a comparative study of the symptoms of 
impending heart, kidney and liver failures based on human 
blood samples acquired from data of patients is investigated 
with a view to ascertain the parameters that could be used to 
infer the state of the heart, kidney and liver. The paper is 
organized as follows. Section 2 presents the causes, 
symptoms and possible diagnostic tests of heart, kidney and 
livers failures. Section 3 investigates some measurable 
blood-related parameters that could be independently or 
collectively used to determine the state of the heart, kidney 
and liver. Detailed discussions of the acquired data based on 
nominal value for normal healthy human beings are also 
presented in this section. Section 4 concludes the paper with 
major highlights on the contributions of the paper and some 
directions on further work. 
2. Heart, Kidney and Liver: Causes, 
Symptoms and Diagnosis 
Heart, kidney and liver failures are most of the 
life-threatening diseases and they have more impact on 
human health [27, 28, 31, 32]. Several research works have 
undertaken to provide more attention in their diagnosis [6–
22]. Various causes, symptoms and diagnosis of heart, 
kidney and liver failures is discussed in the next sub-sections. 
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And the various medical expert systems employed in 
literatures for proper diagnosis is also presented in the 
subsequent sections. 
2.1. The Heart 
2.1.1. Heart Failure 
Heart failure does not mean that the heart has stop working 
rather it means that the heart’s pumping power is weaker than 
normal [25]. With heart failure, blood moves through the 
heart and body at a slower rate and the pressure in the heart 
increases. As a result, the heart cannot pump enough oxygen 
and nutrient to meet the body’s needs [33]. The chamber of 
the heart may respond by stretching to hold more blood to 
pump through the body or by becoming stiff and thickened. 
This helps to keep the body moving, but the heart muscle 
walls may eventually weaken and become unable to pump 
blood efficiently. As a result, the kidneys may respond by 
causing the body to retain fluid (water) and salt [33]. If fluid 
builds up in the arms, legs, ankles, feet, lungs, or other 
organs the body becomes congested and congestive heart 
failure in the term used to describe these conditions. Heart 
failure is a condition in which the heart is no longer able to 
pump out enough oxygen-rich blood. This causes symptoms 
to occur throughout the body [6–9, 25]. 
2.1.2. Causes of Heart Failure 
Conditions that damage or overwork the heart muscle can 
cause heart failure [25]. Overtime the heart weakness. It is 
not able to fill with and/or pump blood as well as it should. 
As the heart weakness, certain proteins and substances might 
be released into the blood. These substances have a toxic 
effect on the heart and blood flow, and they worsen heart 
failure. According to [6–9, 31, 33–35], the most common 
causes of heart failure are coronary heart disease (CHD), 
high blood pressure, heart attack, cardiomyopathy and 
diabetes. 
1) Coronary Heart Disease (CHD): Coronary heart 
disease is a condition in which a waxy substance called 
plaque builds up inside the coronary arteries. These 
arteries supply oxygen-rich blood to the heart muscle 
[34, 35]. Plaque narrows the arteries and reduces blood 
flow to the heart muscle. The build-up of plaque also 
makes it more likely that blood clots will form in the 
arteries. Blood clots can partially or completely block 
blood flow. CHD can lead to chest pain or discomfort 
called angina, a heart attack, heart damage or even 
death [34, 35]. 
2) High Blood Pressure: Blood pressure (BP) is the force 
of blood pushing against the walls of the arteries [24]. 
If this pressure rises and stays high over time, it can 
weaken the heart and lead to plaque build-up. Blood 
pressure is considered high if it stays at or above 
140/90 mmHg overtime [33]. The mmHg is 
millimetres of mercury - the units used to measure 
blood pressure. If someone have diabetes or chronic 
kidney disease, high blood pressure is defined as 
130/80 mmHg or high [34, 35]. 
3) Heart Attack: A heart attack occurs when a coronary 
artery becomes suddenly blocked, stopping the flow of 
blood to the heart muscle. A heart attack damages the 
heart muscle, resulting in a scarred area that do not 
function properly [34, 35]. 
4) Cardiomyopathy: Damages to the heart muscle from 
causes other than artery blood flow problems, such as 
from infections or alcohol or drug abuse [34, 35]. 
5) Diabetes: Diabetes is a disease in which the body’s 
blood glucose (sugar) level is too high. The body 
normally breaks down food into glucose and then 
carries it to cells throughout the body [36]. The cells 
use a hormone called insulin to turn the glucose into 
energy [36]. In diabetes, the body doesn’t make 
enough insulin or doesn’t use its insulin properly. Over 
time, high blood sugar level can damage and weaken 
the heart muscle and the blood vessels around the heart, 
leading to heart failure [31, 34, 35]. 
2.1.3. Symptoms of Impending Heart Failure 
Symptoms of heart failure often begin slowly. At first, 
they may only occur when patient are very active [6–9, 31, 
33–35]. Overtime, the patient may notice breathing problems 
and other symptoms even when he/she is resting. Symptoms 
may also appear suddenly after the heart is damaged from 
heart attack or other problems [31, 34, 35]. 
Common symptoms of Heart failure are [6–9, 25, 31, 33–
35]: 1). Shortness of breath (dyspnea) when you exert 
yourself or when you lie down; 2). Fatigue and weakness; 3). 
Swelling (edema) in the legs, ankles and feet; 4). Rapid or 
irregular heartbeat; 5). Reduced ability to exercise; 6). 
Persistent cough or wheezing with white or pink blood–
tinged phlegm; 7). Increased need to urinate at night; 8). 
Swelling of abdomen (ascites); 9). Sudden weight gain from 
fluid retention; 10). Lack of appetite and nausea; 11). Sudden, 
severe shortness of breath and coughing up pink foamy 
mucus; 12). Elevated blood pressure; and 13). Chest pain, if 
the heart failure is caused by a heart attack. 
All of these symptoms are the result of fluid buildup in the 
body. When symptoms start, one may feel tired and short of 
breath after routine physical effort, like climbing stairs. As 
the heart grows weaker, symptoms get worse. One may begin 
to feel tired and short of breathe after getting dressed or 
walking across the room. Some people may have shortness of 
breath while lying flat. Fluid build-up from heart failure also 
causes weight gain, frequent urination, and a cough that’s 
worse at night and when lying down. This cough may be a 
sign of acute pulmonary edema and it is a condition in which 
too much fluid builds up in the lungs. This condition requires 
emergency treatment. 
2.1.4. Tests and Diagnosis of Heart Failure 
To diagnose heart failure, doctor will take a careful 
medical history and perform a physical examination. The 
doctor will also check for the presence of risk factors such as 
high blood pressure. Using a stethoscope, the doctor can 
listen to the lungs for signs of congestion. The stethoscope 
also picks up abnormal heart sounds that may suggest heart 
35 Reginald A. O. Osakew et al.:  Comparative Study of the Symptoms of Impending Human   
Heart, Kidney and Liver Failures Based on Blood Samples 
failure. The doctor may examine the veins in the neck and 
check for fluid build-up in the abdomen and legs. After the 
physical exam the doctor may also order some of these tests 
[6–9, 25, 31, 33–35]:  
1) Blood Tests: The doctor may take a sample of some 
blood to check for the kidney and thyroid function and 
to look for indications of other disease that affect the 
heart. A blood test to check for a chemical called 
N-terminal pro-B-type natriuretic peptide (NT-pro BNP) 
can help in diagnosing heart failure. 
2) Chest X-ray: X-ray images helps the doctor to see the 
condition of the lungs and heart. In heart failure, 
patient’s heart may appear enlarged and fluid build-up 
may be visible in the lungs. The doctor can also use an 
x-ray to diagnose conditions other heart that may 
explain the signs and symptoms. 
3) Electrocardiogram (ECG): This test records the 
electrical activity of the heart through electrodes 
attached to the skin and impulses are recorded as waves 
displayed on a monitor or printed on paper. This test 
helps the doctor diagnose heart rhythm problems and 
damage to the heart from a heart attack that may be 
underlying heart failure. 
4) Myocardial Biopsy: In this test, doctor will inserts a 
small flexible biopsy cord into a vein in the neck or 
groin, and small pieces of the heart muscle are taken. 
This test is performed to diagnose certain types of heart 
muscle diseases that cause heart failure. 
2.2. The Kidney 
2.2.1. Kidney and Kidney Disease 
The kidneys are two organs located on either side of the 
spine in the middle at the back, just above the waist. They 
perform several life sustaining roles: They cleanse the blood 
by removing waste and excess fluid maintain the balance of 
salt and minerals in the blood, and help to regulate blood 
pressure. When the kidneys become damaged, waste 
products and fluids can build up in the body, causing 
swelling in the ankles, vomiting, weakness, poor sleep and 
shortness of breath. If the kidney is left untreated, diseased 
kidneys may eventually stop functioning completely. Loss 
of kidneys functions is a serious and potentially fatal 
condition. 
Healthy kidneys handle several specific roles such as [10–
16]: 1). Maintain a balance of water and concentration of 
minerals, such as sodium, potassium, and phosphorus in the 
body; 2). Remove waste by–products from the blood after 
digestion, muscle activity and exposure to chemicals or 
medications; 3). Produce rennin, an enzyme that helps 
regulate blood pressure; 4). Produce erythropoietin, which 
stimulates red blood cell production; and 5). Produce an 
active form of vitamin D, needed for bone health. 
2.2.2. Kidney Failure: What to Expect 
For an impending kidney failure, one or more of the 
following should be expected and/or answered: 1). How 
does kidney failure affect a person’s health?; 2). When is 
uremia likely to occur?; 3). Can uremia be avoided?; 4). 
How does kidney failure affect the blood?; 5). How does 
kidney failure affect the heart and blood vessels?; and 6). 
How does kidney failure affect appetite? A brief detail of 
the above six expectations are briefly discussed as follows 
[10–16, 25]: 
1) How Does Kidney Failure Affect a Person’s Health?  
Kidney failure can affect a person’s health is several 
way. Some people experience fatigues some lose their 
appetite, and some have leg cramps [25]. These problems 
are caused by waste products that build up in the blood, a 
condition known as uremia. Healthy kidneys remove waste 
products from the blood. When the kidneys stop working 
uremia occurs. The kidney also produces hormones and 
balances the minerals in the blood [25]. When the kidneys 
stop working, most people develop condition that affect 
the blood, bones, nerves and skin. In addition to fatigue, 
loss of appetite, leg cramps, some of the more common 
problems caused by kidney failure are itching, sleeping 
problems, restless legs, weak bones, joint problems, and 
depression. 
2) When is Uremia Likely to Occur? 
It occurs when a person reaches the final stages of chronic 
kidney disease (CKD), people with CKD often feel no 
symptoms until the kidneys are severally damaged. Usually 
when people develop symptoms, their kidney failure has 
progressed to the point where they must have regular blood – 
filtering treatments called dialysis or receive a kidney 
transplant to stay alive. Kidney failure treated by dialysis or 
transplant is called end–stage renal disease (ESRD). The 
word “renal” refers to the kidneys. Even people who have 
dialysis treatments can eat foods not recommended for 
people on dialysis [37]. 
3) Can Uremia be Avoided?  
People with kidney failure can avoid most of the problems 
of uremia by having regular dialysis treatments and limiting 
foods that contain sodium, potassium and phosphorus. People 
who have CKD should see a kidney specialist – called 
nephrologists regularly to track the progression of the disease 
so they can begin appropriate treatment before uremia occurs. 
Even though health care providers can treat most of the 
complications of CKD and ESRD, people with these 
conditions should know what to expect when their kidneys 
fails [10–16]. 
4) How does Kidney Failure Affect the Blood? 
In addition to uremia, kidney failure can also cause anemia, 
a condition in which the red blood cells are fewer or smaller 
than normal which means less oxygen is carried to the body’s 
cells. Anemia is common in people with CKD, as well as 
those on dialysis, because the damaged kidneys slow the 
production of the hormone erythropoietin (EPO), which helps 
the bone marrow make red blood cells. Less EPO means the 
body has fewer red blood cells resulting in anemia. 
Asynthetic form of EPO is commonly prescribed for people 
on dialysis [10–16]. 
5) How does kidney Failure Affect the Heart and Blood 
Vessels? 
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People with kidney failure, particularly dialysis patients 
have far higher rates of heart and blood vessels problems 
than people without kidney problems Heart attacks are the 
leading cause of hospitalization and death among dialysis 
patients. Kidney failure also raises the risk of other 
cardiovascular problems such as blockage of blood to the 
heart and congestive heart failure. People who have kidney 
failure need to monitor their cardiovascular health, take all 
prescribed medications, and follow their health care 
provider’s instructions for diet and exercise [10–16]. 
6) How does kidney Failure Affect the Appetite? 
People who have uremia often lose their appetite, some 
people find that food tastes different while some no longer 
like food they once craved for. In fact, many people feel sick 
to their stomach at the thought of eating. But getting enough 
protein and calories is important for staying healthy. People 
with kidney failure should talk with the renal dietitian at their 
dialysis clinic or transplant center to find foods that are 
appealing and provide needed nutrients [10–16]. 
2.2.3. Causes of Kidney Failure 
The possible causes of kidney failure include but not 
limited to the following [10–16, 25]: 1). Diabetic 
Nephropathy: Even if it is well managed, diabetes can cause 
kidney damage; 2). Hypertension: High blood pressure; 3). 
Glomerulonephritism: Swelling or inflammation of the tiny 
filtering units (nephrons) in the kidney; 4). Polycystic Kidney 
Disease: An inherited condition that causes hundreds of 
crystals to form in the kidneys; and 5). Reflex Nephropathy: 
A bladder–value problems that allows urine to flow back into 
the kidney causing scarring. 
2.3. The Liver 
The liver is a vital organ of the digestive system present in 
vertebrates and some other animals. It has a wide range of 
functions including detoxification, protein synthesis, and 
production of biochemical necessary for digestion [17–22, 
33]. The liver is necessary for survival because there is 
currently no way to compensate for the absence of liver 
function in the lung term, although new liver dialysis 
techniques can be used in the short term. This gland plays a 
major role in metabolism and has a number of functions in 
the body, including glycogen storage, decomposition of red 
blood cells, plasma protein synthesis, hormone production, 
and detoxification [24]. It lies below the diaphragm in the 
abdominal – pelvic region of the abdomen. It produces bile, 
an alkaline compound which aids in digestion via the 
emulsification of lipids. The liver’s highly specialized tissues 
regulate a wide variety of high–volume biochemical 
reactions, including the synthesis and breakdown of small 
and complex molecules, many of which are necessary for 
normal vital functions [38]. 
The big question is “What are the basic functions of the 
liver?”. The liver is located in the right upper portion of 
the abdominal cavity just beneath the right side of the rib 
cage. The liver has many functions that are vital to life. 
Some of the important functions of the human liver are: 1). 
Detoxification of blood; 2). Production of important 
clotting factors, albumin, and many other important 
proteins; 3). Metabolizing (processing) medications and 
nutrients; 4). Processing of waste products of haemoglobin 
and other cells; and 5). Storing of vitamins, fat, cholesterol, 
and bile. 
Liver Failure 
Liver failure occurs when large parts of the liver become 
damaged beyond repair and the liver is no longer able to 
function. Liver failure is a life–threatening condition that 
demands urgent medical care. Most often, liver failure occur 
gradually and over many years. However, a more rare 
condition known as acute liver failure occur rapidly (as little 
as 48 hours) and can be difficult to detect initially [25, 33]. 
Although the list of possible causes of live failure could be 
exhaustive and liver failure could be as a result of severe 
deterioration in liver function which could be attributed to 
one and/or more of the following [17–23, 25, 33]: 1). Liver 
failure is caused by a disorder or substance that damages the 
liver; 2). Most people have jaundice, feel tired and weak, and 
lose their appetite; 3). Other symptoms include accumulation 
of fluid within the abdomen (ascites) and a tendency to bruise 
and bleed easily; 4). Doctors can usually diagnose liver 
failure based on symptoms and results of a physical 
examination and blood tests; and 5). Treatment usually 
involves controlling protein consumption, limiting sodium in 
the diet, completely avoiding alcohol, and treating the cause, 
but sometimes liver transplantation is required. Liver failure 
can result from any type of disorder, including viral hepatitis, 
cirrhosis, and liver damage from alcohol or drugs such as 
acetaminophen. 
Many effects that could occur due to the malfunctioning 
of the liver may include but not limited to the following: 1). 
The liver can no longer adequately process bilirubin (a 
waste product formed when old red blood cells are broken 
down) so that it can be eliminated from the body. Bilirubin 
then builds up in the blood and is deposited in the skin. The 
result is jaundice; 2). Liver can no longer synthesize enough 
of the proteins that help blood clot. The result is a tendency 
to bruise and bleed (coagulopathy); 3). Blood pressure in 
the veins that bring blood from the intestine to the liver is 
often abnormally high (called portal hypertension); 4). 
Fluid may accumulate within the abdomen (ascites); and 5). 
Brain function may deteriorate because the liver cannot 
remove toxic substances as it normally does. These 
substances build-up in the blood and causes brain functions 
to deteriorate. This disorder is called hepatic 
encephalopathy. 
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Table 1. Measurable blood-related heart, kidney and liver parameters. 
 Heart Parameters Kidney Parameters Liver Parameters 
1 Pulse rate and rhythm Packed cell volume/blood cells Bilirubin and bile salt levels 
2 
Arterial blood gas such as oxygen 
(O2) and carbon IV oxide (CO2) 
Electrolytes (Na+, K+, Cl+, creatinine, 
urea, uric acid, Ca2+, PO
4
− ) Protein 
3 
Arterial pressure and blood 
pressure 
Erythropoietin 
Clotting factors (II, V, X) in terms of prothrombin time (PT) and 
international normalized ratio (INR) 
Vitamin D level NH4 or urea, α-feto (alpha-feto) protein, Glucose level 
Table 2. Minimum and maximum values of the all the parameters considered for the study. 
S/N Measured blood parameters and their units Minimum value Maximum value 
1. Heart beats (number of heat beats per minute) 65 105 
2. Mean arterial pressure (mmHg) 65 115 
3. Systolic blood pressure (mmHg) 85 150 
4. Diastolic blood pressure (mmHg) 60 110 
5. Packed cell volume (%) 33 53 
6. Erythropoietin (mu/ml) 4 26 
7. Electrolyte Na+ (mol/l) 118 143 
8. Electrolyte K+ (mol/l) 3 5 
9. Electrolyte Cl– (mol/l) 92 113 
10. Electrolyte Ca+ (mol/l) 2 3 
11. Ceratine (Umol/l) 48 133 
12. Glucose fasting (mol/l) 2 6 
13. Glucose random (mol/l) 4 7 
14. Urea (mmol/l) 60 110 
15. Direct bilirubin (mg/dl) 0.0027 0.4973 
16. Total bilirubin (direct and indirect) (mg/dl) 0.1000 2.2000 
17. Vitamin D level (mg/ml) 0 40 
18. Ammonia level (mcg/dl) 9 80 
19. Alpha-feto protein (ng/ml) 7 500 
 
3. Problem Formulation, Materials and 
Methods 
3.1. Problem Formulation: Measurable Blood-Related 
Heart, Kidney and Liver Parameters 
The focus here is to investigate how the symptoms of 
impending heart, kidney and liver failures could be detected 
in a given blood sample. Interactions with medical experts 
and ideas from reviewed literature revealed that some key 
factors which should be observed in order to suspect, detect 
or ascertain the symptoms of impending heart, kidney and 
liver failures based on blood sample from human beings are 
summarized in Table 1. 
1) The Heart: 
(1) The pulse is how many times per minute that the 
artery expands and contracts in response to the heart 
pulse rate which is also called heartbeat. Normal 
adult resting heartbeat is between 60 – 100 
heartbeats per minute; 
(2) Mean arterial pressure is between 60 mmHg or 
greater is needed to maintain adequate tissue per 
fusion; and 
(3) The blood pressure consist of the systolic which 
must be less than or equal to 140 mmHg while the 
diastolic must be less than or equal to 90 mmHg. 
2) The Kidney: 
(1) Packed cell volume / blood cell: (a) Male should be 
between 40 – 50% and (b) Female should be 
between 35 – 44%; 
(2) Erythropoetin should be between (4 – 24 mu/ml); 
and 
(3) Electrolytes: (a) Na+ should be between (120 – 140 
mol/l); (b) K
+
 should be between (3 – 5 mol/l); (c) 
Cl
+
 should be between (95 – 110 mol/l); (d) Ca
+
 
should be between (2.25 – 2.75 mol/l); (e) 
Creatinine (male and female) should be between (50 
– 130 Umol/l); (f) Urea should be between (2.0 – 6.0 
mmol/l); (g) Glucose fasting should be between 3.0 
– 5.5 mol/l; and (h) Glucose random should be 
between 4.4 – 7.0 mol/l 
 
 International Journal of Chinese Medicine 2017; 1(2): 32-44 38 
 
 
 
Figure 1. Variations of (a) heart beat per minute and (b) arterial blood pressure. 
 
Figure 2. Blood pressure: (a) Systtolic blood pressure (mmHg) and (b) Diastolic blood pressure (mmHg). 
3) The Liver: 
(1) Bilirubin: Normal values of direct (conjugated) 
bilirubin are from 0.0 – 0.3 mg/dl. Normal values of 
total bilirubin (direct and indirect) are from 0.3 – 1.9 
mg/dl; 
(2) Vitamin D Level: The normal range of vitamin D is 
wide but typically between 20 – 40 mg/ml and in some 
cases between 50 – 100 mg/ml; and 
(3) Ammonia Level: (a) Adult is between 9.5 – 49 mcg/dl; 
(b) Children is between 40 – 80 mcg/dl and (iv) 
alpha-feto protein: Normal levels are below 10 ng/ml. 
3.2. Discussion of the Heart, Kidney and Liver 
Experimental Data 
A total of 368 data each for 16 out of the 19 measurable 
blood-related parameters listed in the previous Sub-section 
were collected from different hospitals in Akure, Ondo State, 
Nigeria. For confidential and security reasons, the bio-data 
and information for the patients from the where the data were 
collected have been skipped in this paper. From our 
comparative study, the 16 attributes of interest that could be 
acquired from the hospitals contacted which could be used to 
detect heart, kidney and liver failure for: (1) Heart beat per 
minutes, (2) mean arterial pressure (mmHg), (3) systolic Bp 
(mmHg), (4) diastolic Bp, (5) potassium, (6) chlorine, (7) 
calcium, (8) creatine (umol/l), (9) glucose fasting (mol/l), (10) 
glucose random (mol/l), (11) urea (mmol/l), (12) direct 
bilirubin (mg/dl), (13) total bilirubin (mg/dl), (14) Vitamin D 
(ng/ml), (15) ammonia (mcg/dl), and (16) alpha-feto (ng/ml). 
Figure 1 to Figure 6 shows the variations of these attributes 
from the test data collected for 368 patients which are 
discussed as follows. Furthermore, the minimum and 
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maximum values of the 19 measureable blood-related 
parameters are listed in Table 2. 
Figure 1(a) and (b) shows the variations of heart beat per 
minute and arterial pressure from the 368 patients 
respectively. The normal heart beat of a human being is 
between 60-100 or 65-105 per minute, normal arterial 
pressure (blood pressure) ranges from 100/60–140/80 mmHg 
if the patient arterial pressure (blood pressure) is around 
150/100 mmHg the lifestyle changes and the use of medicine 
can improve the condition of the patient. Any patient with 
arterial pressure (blood pressure) of 180/80 mmHg upward is 
not a normal patient [6–9, 25], such patient should be 
monitored by a doctor and he/she will have to follow up 
appointment at least every 3 to 6 months, but sometimes 
much more often. The doctor will also have to carry out tests 
to check the heart functions. Additionally, the doctor will 
also need to know the state of the patient and the symptoms 
that will inform the doctor whether or not the heart failure is 
getting worse; which will guide the doctor to help the patient 
stay healthier even when he/she is out of the hospital. While 
out of hospital, the patient should be monitored for changes 
in the heart rate, heart pulse, blood pressure and weight. Also 
patients with blood pressures of 190/100 mmHg upward are 
amongst the leading cause of sudden deaths globally [6–9, 
25]. In order to control the risks associated with the disease, 
it is crucial to monitor weight gain, especially over a day or 
two. This can be a sign that the body is holding onto extra 
fluid and the heart failure is getting worse. For middle-aged 
and older-aged, high blood pressure is an important indicator 
for cardiovascular diseases, which are amongst the leading 
cause of sudden deaths [6–9, 25]. 
Figure 2(a) and (b), shows the systolic blood pressure (in 
mmHg) and diastolic blood pressure (in mmHg) respectively. 
Systolic heart failure is when the heart muscles cannot pump 
(eject) blood out of the heart very well while diastolic heart 
failure is when the heart muscles are stiff and do not fill up 
with blood easily which makes it a vital attributes of the blood 
as a parameter that could be used to infer the state of health of 
an individual [2]. Normal systolic blood pressure ranges from 
85 to 150 mmHg. If the patient experiences more than 90/160 
mmHg such patient lifestyle changes and the use of medicine 
can improve the condition of the patient [25]. On the other 
hand, if it is not up 80 mmHg at a certain point the health care 
provider will decide whether it is best to keep treating 
aggressively the patient along with his/her family and doctor 
may want to discuss palliative or comfort care at this time. 
Diastolic blood pressure ranges from 60 to 110 mmHg. If the 
patient experiences blood pressure above 80/120 mmHg the 
patient lifestyle changes and if it is below 60 mmHg the use of 
medicine can improve the condition of the patient [25]. It is 
important that the patient take his/her medicine as prescribed 
and directed by the doctor directed, they should not take any 
drugs or herbs without first asking the doctor or nurse about 
them, because there are some drugs that can make heart failure 
worse. Such drugs include Ibuprofen and Naproxen. The only 
prevention is by living a healthy lifestyle and reducing the risk 
for heart disease [2, 4, 6–9, 25]. 
Figure 3(a), (b) and (c) shows, potassium (k
+
) (in mol/l), 
chlorine (Cl
+
) (in mol/l) and calcium (Ca
+
) (in mol/l) 
respectively. Normal electrolyte potassium (mol/l) ranges 
from 3 to 5 mol/l. If the patient electrolyte potassium is 
around 5 upward or below 3 mol/l, the lifestyle changes and 
the use of medicine can improve the condition of the patient 
[10–16, 25]. Normal electrolyte chlorine (mol/l) ranges from 
95 to 110 mol/l or 92 to 113 mol/l. If the patient electrolyte 
chlorine (in mol/l) is around 90/120, the lifestyle changes and 
if the patient is below 90 mol/l the use of medicine can 
improve the condition of the patient. Any patient with 
100/130 mol/l or above is not a normal patient and are 
amongst the leading cause of sudden deaths. Normal 
electrolyte calcium (mol/l) ranges from 2.25 to 2.75 mol/l or 
2.22 to 2.78 mol/l [25]. If the patient electrolyte calcium is 
around 2.35 to 2.85, the patient’s lifestyle will change. 
Maintaining a balance of water and concentration of minerals 
such as potassium, chlorine and calcium in the blood, remove 
waste by-products from the blood after digestion, controls 
muscle activities, and combats exposure to chemicals or 
excess and/or misuse of medications, it helps filter waste 
excess fluid and toxins from the blood. They are also 
important for blood cell production and bone health. If the 
kidney does not work properly [25], harmful substances build 
up in the body, blood pressure can rise and too much fluid 
can collect in the body’s tissues, which leads to swelling 
electrolyte levels in the blood and may be abnormally high or 
low because of improper filtering. The only prevention is by 
controlling blood pressure which will slow further kidney 
damage, Angiotensin converting enzyme (ACE) inhibitors or 
angiotensin receptor blockers (ARBs) are used most often 
with a goal to keep blood pressure at or below 130/80 mmHg 
[10–16, 25]. 
Figure 4(a), (b) and (c) show the distribution of creatinine 
(in Umol/l), glucose fasting (in mol/l) and glucose random 
(in mol/l) respectively for the present study. Creatinine 
(Umol/l) is a waste product that comes from the normal wear 
and tear on muscles of the body. Creatinine levels in the 
blood can vary depending on age, race and body size. It is a 
chemical waste molecules that is generated from muscles 
metabolism [10–16, 25]. Normal creatinine for both male and 
female ranges between 50 and 130 Umol/l [10–16, 25]. The 
lower range is 50 while the higher range is 130 Umol/l in 
normal human beings. If it is greater or less than this range 
the lifestyle of the individual changes and the use of 
medicine can improve the condition of the patient [25]. In 
order to control the risk associated with the diseases, it is 
crucial to monitor the creatinine level of the patient 
frequently. The normal range for glucose fasting is between 
3.0 and 5.5 mol/l while the normal range for glucose random 
ranges from 4 to 7 mol/l, most people do not have any kidney 
problem from taking medicines. But people who have serious, 
long-time health problem are more likely than other people 
who have a kidney problem from medicine [25]. For example, 
medicines that can sometimes harm the kidney include; 
antibiotics such as gentamicin and streptomycin. For people 
who are on dialysis or approaching total kidney failure, 
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adequate nutrition is important for maintaining energy, 
strength, healthy sleep pattern, bone health, heart health and 
good mental health. An individual’s state of health will 
dictate the type of treatment that should be administered.  
 
Figure 3. (a) Potassium (k+) (mol/l), (b) chlorine (cl+) (mol/l) and (c) calcium (ca+) (mol/l). 
 
Figure 4. (a) Creatinine (Umol/l), (b) glucose fasting (mol/l) and (c) glucose random. 
 
Figure 5. (a) urea (mmol/l), (b) total bilirubin direct and (c) bilirubin direct. 
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Figure 6. (a) vitamin D level, (b) ammonia and (c) alpha-feto protein. 
To determine whether someone has this disease, he or she 
may need tests and procedures such as blood test to look for 
the level of waste products such as creatinine and urea in the 
blood [10–16, 25].  
Figure 5(a), (b) and (c) shows, urea (in mmol/l), direct 
bilirubin (in mg/dl) and total bilirubin (direct and indirect 
with units in mg/dl) respectively. Urea in normal humans 
ranges from 60 mol/l to 110 mol/l as shown in Figure 5(a). If 
it is less than or not equal to these normal ranges, it implies 
that the patient lifestyle changes and the use of medicine can 
improve the health condition of the patient. Any patient with 
urea of 70/120 (mmol/l) upward is not a normal patient or 
patient with 80/140 upward is among the leading cause of 
sudden deaths [17–22, 25]. In order to control the risks 
associated with the diseases, it is crucial to monitor the urea 
of the patient frequently. The normal values of direct 
(conjugated) bilirubin are from 0 to 0.3 mg/dl while normal 
values of total bilirubin (direct and indirect) are from 0.3 to 
1.9 mg/dl [25]. Urinary bilirubin is normally absent but is 
conjugated when present (dark urine). Normal or raised 
urinary bilirubin with elevated urobilinogen suggests 
hepatocellular failure or increased red cell breakdown (e.g. 
haemolytic jaundice). If clinically jaundiced but serum 
bilirubin normal and negative urinary bilirubin, then the 
cause is hypervitaminosis A or high serum carotene from 
carrots, pumpkins, etc. A treatment depends on the cause and 
the specific symptoms. The urgency of treatment depends on 
whether liver failure is acute or chronic, but the principles of 
treatment are the same. The patient is usually placed on a 
restricted diet to limit the amount of animal protein, 
particularly in red meat but also in fish, cheese and eggs. To 
make sure people get enough protein, doctors advise them to 
eat more food that contains vegetables, protein (such as soya). 
The patient should also limit their consumption of sodium (in 
salt and many foods). Doing so can help prevent fluid from 
accumulating within the abdomen. Alcohol should be 
completely avoided because it can worsen liver damage [17–
22, 25, 30].  
Figure 6(a), (b) and (c) shows vitamin D level, ammonia 
and alpha-feto variations respectively from the data collected. 
The normal vitamin D level is between 20 and 40 ng/ml. If 
the patient’s vitamin D level is around 25 to 45 the lifestyle 
changes and the use of medicine can improve the condition 
of the patient. Any patient with vitamin D level 30 to 70 
upward is not a normal patient. Vitamin D level of more than 
70 ng/ml is amongst the leading causes of sudden deaths. In 
order to control the risks associated with the disease it is 
crucial to monitor the vitamin D level of the patient 
frequently. For middle-aged and older aged, vitamin D is 
very important for the body and it must not be low or high. 
Normal ammonia in the body is between 90 or 80 mcg/dl 
while alpha-feto protein mg/ml ranging from 7 to 500 ng/ml. 
Moderate level of alpha-feto protein of up to 500 ng/ml can 
be seen in patients respectively. While the use of medicine 
can improve the condition(s) of a patient with impending 
liver failure, in order to control the risk associated with the 
disease, it is crucial to monitor the ammonia and alpha-feto 
protein of the patient frequently [17–22, 25, 30]. 
4. Conclusion and Future Directions 
The paper has presented a comparative study of the 
symptoms of impending human heart, kidney and liver 
failures based on blood samples. The study identified 25 
measurable blood-related parameters for heart, kidney and 
liver out of which 368 experimental data for 19 of the 
parameters were obtained from 4 different specialist hospitals 
in Akure, Ondo State, Nigeria whereas 6 of the parameters 
were not available from any of the consulted hospitals for 
most patients. The 19 measurable blood-related parameters 
with experimental data are (see Table 2): 1). Heart: heart 
beat, mean arterial blood pressure, systolic blood pressure, 
diastolic blood pressure; 2). Kidney: packed cell 
volume/blood cells, erythropoietin, electrolyte Na
+
, 
electrolyte Cl
-
, electrolyte Ca
2+
, vitamin D; and 3). Liver: 
Ceratine, glucose fating, glucose random, urea, direct 
bilirubin, total bilirubin (direct and indirect), ammonia level, 
alpha-feto protein. The 6 measurable blood-related 
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parameters without experimental data are (see and compare 
Table 1 and Table 2): 1). Heart: arterial blood gases such as 
(i) Oxygen (O2) and (ii) Carbon IV oxide (CO2); 2). Kidney: 
(i) Electrolyte (
4PO
−
); and 3). Liver: (i) Clotting factors (II, 
V, X) in terms of prothrombin, (ii) international normalized 
ratio (INR), (iii) bile salt levels. 
Critical examination of the heart, kidney and liver under 
the following topics, namely: (i) functions, (ii) causes of their 
failures, (iii) symptoms of impending failures, (iv) tests and 
diagnosis, and (v) preliminary medical advice and 
suggestions on possible ways to manage any symptom(s) or 
any impending failures have been detailed and presented in 
this study. It should be noted that this study does not, in any 
way, cover treatment issues on any of the organ(s) failures 
but rather attempts to identify the possible measurable 
blood-related parameters that could be used to deduce and 
infer the state of human health. Extensive discussions of and 
deductions from the experimental data with their respective 
minimum and maximum values together with their respective 
nominal values as far as Ondo State, Nigeria is concerned has 
been well presented for health monitoring when these 
respective values are out of range. 
Medical expert system is a challenging field, requiring 
the synergy of different scientific areas. The representation 
of medical knowledge and expertise, the decision making in 
the presence of uncertainty and imprecision, and the choice 
and adaptation of a suitable model are some issues that a 
medical expert system should take into consideration [39, 
40]. Uncertainty is traditionally treated in a probabilistic 
manner; recently, however, methods based on neuro-fuzzy 
logic have gained special attention. In the medicine area, 
many expert systems were designed for the diagnosis and 
treatment of diseases. Fuzzy expert system has found 
applications in many areas, among these medical 
engineering has evolved as one of the key application area 
of computational intelligence [41, 42]. In the last decade, 
specifically between 2003 and 2012, a major application 
area of fuzzy expert system includes diagnosis like local 
anaesthesia, appendicitis, brain tumor, breast cancer, 
cardiovascular disease, clinical diagnosis, diabetes, 
electrocardiogram (ECG) signal evaluation, hypertension 
diagnosis, liver disorder, lung disease, ovarian cancer, 
prostate cancer, pulmonary infection, urinary tract infection, 
prenatal disease detection etc [41–45]. 
Finally, the development of an adaptive classification 
algorithm that could be used to classify the state of human 
health on the basis of the experimental data obtained and 
used in this study could be considered as a future study with 
a view on the development of an online real-time electronic 
health (e-health) monitoring system design and deployment. 
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